KELSEY RUSSELL: Open Payments
NPI 1972238376 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,690 in 79 payments from 17 companies in 2025. Trend: 2023 $1,659 · 2024 $2,281 · 2025 $1,690
Food & beverage: $1,690
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $322 |
| AstraZeneca Pharmaceuticals LP | 13 | $286 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $175 |
| PFIZER INC. | 8 | $157 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| Intra-Sana Laboratories | 1 | $107 |
| Amgen Inc. | 5 | $99 |
| Lilly USA, LLC | 4 | $96 |
| Kowa Pharmaceuticals America, Inc. | 4 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
Products named: AIRSUPRA, Kerendia, Wegovy, RELTONE 200 MG, JARDIANCE, NURTEC ODT, OTEZLA, ELIQUIS.
Industry payments across NV — which companies pay providers there.
